These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Separate histogenesis of combined hepatocellular and cholangiocellular carcinoma in two patients. Nagafuchi Y; Okamoto K; Shono M; Higure A; Todoroki H; Itoh H; Takeda S; Katumoto F; Toyoshima S Hepatogastroenterology; 1998; 45(20):523-7. PubMed ID: 9638442 [TBL] [Abstract][Full Text] [Related]
49. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin. Asayama Y; Taguchi Ki K; Aishima Si S; Nishi H; Masuda K; Tsuneyoshi M Liver; 2002 Feb; 22(1):43-50. PubMed ID: 11906618 [TBL] [Abstract][Full Text] [Related]
51. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. Fukukura Y; Taguchi J; Nakashima O; Wada Y; Kojiro M J Comput Assist Tomogr; 1997; 21(1):52-8. PubMed ID: 9022770 [TBL] [Abstract][Full Text] [Related]
52. Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma. Rosa M; Mohammadi A Diagn Cytopathol; 2014 May; 42(5):431-5. PubMed ID: 23008149 [TBL] [Abstract][Full Text] [Related]
53. [Classification of degree of liver damage and cancer stage]. Yamasaki S Nihon Rinsho; 2001 Oct; 59 Suppl 6():222-6. PubMed ID: 11761944 [No Abstract] [Full Text] [Related]
55. Histological heterogeneity in primary and metastatic classic combined hepatocellular-cholangiocarcinoma: a case series. De Vito C; Sarker D; Ross P; Heaton N; Quaglia A Virchows Arch; 2017 Nov; 471(5):619-629. PubMed ID: 28707055 [TBL] [Abstract][Full Text] [Related]
56. Combined hepatocellular cholangiocarcinoma: Controversies to be addressed. Wang AQ; Zheng YC; Du J; Zhu CP; Huang HC; Wang SS; Wu LC; Wan XS; Zhang HH; Miao RY; Sang XT; Zhao HT World J Gastroenterol; 2016 May; 22(18):4459-65. PubMed ID: 27182157 [TBL] [Abstract][Full Text] [Related]
57. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings. Nagaoka S; Itano S; Ishibashi M; Torimura T; Baba K; Akiyoshi J; Kurogi J; Matsugaki S; Inoue K; Tajiri N; Takada A; Ando E; Kuromatsu R; Kaida H; Kurogi M; Koga H; Kumashiro R; Hayabuchi N; Kojiro M; Sata M Liver Int; 2006 Sep; 26(7):781-8. PubMed ID: 16911459 [TBL] [Abstract][Full Text] [Related]
58. Hepatocellular-cholangiocarcinoma with sarcomatous change: Clinicopathological features and outcomes. Qian YR; Jiang N; Liu P; Zhang XF; Liu XM; Lv Y; Xiang JX Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):574-578. PubMed ID: 33934975 [No Abstract] [Full Text] [Related]
59. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation. Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046 [TBL] [Abstract][Full Text] [Related]